• Mashup Score: 25

    June Webinar Join Us for Our Upcoming Webinar on June 19 from 6:30 -7:30 pm! Approved by the ASRT for 1 Category A CME. Free for MembersNon-member registration fee: $15.00 Not a member yet? Consider joining today to enjoy exclusive benefits like free webinars! Registration Details: A Zoom link will be sent to all participants one week

    Tweet Tweets with this article
    • Come join me this month for a webinar on improving quality and recognition of Aortic Stenosis hosted by the PA Association of Sonographers (https://t.co/mfWNKeQTJF) @ASE360 @DVESociety @pattypellikka @ottoecho @PPibarot @mariellesc1 https://t.co/WkMBJf0kbN

  • Mashup Score: 2

    Background Orthostatic hypotension (OH) is associated with cardiovascular disease, particularly among older adults. While a standing transthoracic echocardiogram (TTE) could theoretically identify changes in cardiac output to diagnose cardiogenic OH, there are no established protocols for orthostatic TTEs and their feasibility is unknown. Methods and results We recruited 115 patients scheduled for elective outpatient TTE. Consenting participants, who were able to stand safely, underwent their scheduled recumbent TTE, followed by a standing TTE, performed within 1–2 minutes of standing. The focused TTE used the apical window to measure velocity time integral across the aortic valve to assess cardiac output. Blood pressure (BP) was measured in the supine and standing positions and patients were asked about symptoms of dizziness and lightheadedness. OH was defined as a change in standing minus supine systolic BP ≤-20 mm Hg or in diastolic BP of ≤-10 mm Hg. Of the 115 enrolled participants

    Tweet Tweets with this article
    • RT @EchoResPract: 🚨NEW ARTICLE🚨 Standing transthoracic echocardiography: A feasibility study: https://t.co/Z0iBAFfC2F @spjuraschek @noell…

  • Mashup Score: 4

    Ultrasound‐enhancing agents (UEAs) improve diagnostic transthoracic echocardiography (TTE) in selected cardiac patients. UEA use has been embraced by the cardiology community, and there is now an abundance of high‐quality evidence supporting their safety and efficacy. 1, 2 UEA administration routinely salvages nondiagnostic TTEs and can reveal otherwise undetectable cardiac pathology, allowing for timely diagnosis and reducing the need for alternative imaging modalities. It is not an exaggeration to say

    Tweet Tweets with this article
    • 14/ Many thanks to my spectacular coauthors, @HeartDocSharon @trporter58 Kevin Wei @JessicaLeeStout and @michaelleemain and to @JAHA_AHA. Check out the excellent editorial as well: https://t.co/YbwYsPtVsg - thanks for reading. Fin.

  • Mashup Score: 0

    Polyethylene glycols (PEG), or macrogols, are used in high-molecular-weight (HMW) (>1000 g/mol) forms as active ingredients or drug excipients, such as bowel preparations and parenteral steroids.1 We and others have previously reported immediate and life-threatening hypersensitivity reactions to PEG of increasing importance.1 Here, we report on a case of anaphylaxis to PEG 5000–conjugated liposomal perflutren, a perfluorocarbon gas used as echocardiography contrast.

    Tweet Tweets with this article
    • 7/ Recent case reports of severe AEs to UEAs (https://t.co/0GjFzEmBPX) in patients with PEG allergy prompted a new FDA MedWatch report + new warnings for the two PEGylated agents. https://t.co/wRBolduS2R